Literature DB >> 21431855

Bile acid metabolism and the pathogenesis of type 2 diabetes.

Janne Prawitt1, Sandrine Caron, Bart Staels.   

Abstract

Type 2 diabetes (T2D) is a growing health problem worldwide, but the currently available strategies for therapy and prevention are insufficient. Recent observations indicate that bile acid homeostasis is altered in T2D. Bile acids are metabolic regulators that act as signaling molecules through receptor-dependent and -independent pathways. The most prominent signaling molecules mediating bile acid signaling are the nuclear receptor farnesoid X receptor (FXR) and the membrane receptor TGR5. Both are implicated in the regulation of lipid, glucose, and energy metabolism. Dysregulation of these pathways might contribute to the development of T2D and associated complications. Interestingly, data from studies with bile acids or bile acid sequestrants indicate that the manipulation of bile acid homeostasis might be an attractive approach for T2D therapy. In this review, we summarize the mechanisms of bile acid-mediated metabolic control that might be relevant in the pathogenesis of T2D.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21431855      PMCID: PMC3338411          DOI: 10.1007/s11892-011-0187-x

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  48 in total

1.  The bile acid sensor FXR regulates insulin transcription and secretion.

Authors:  Barbara Renga; Andrea Mencarelli; Piero Vavassori; Vincenzo Brancaleone; Stefano Fiorucci
Journal:  Biochim Biophys Acta       Date:  2010-01-07

2.  Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice.

Authors:  Tiangang Li; Erika Owsley; Michelle Matozel; Peter Hsu; Colleen M Novak; John Y L Chiang
Journal:  Hepatology       Date:  2010-08       Impact factor: 17.425

3.  Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes.

Authors:  Umut Ozcan; Erkan Yilmaz; Lale Ozcan; Masato Furuhashi; Eric Vaillancourt; Ross O Smith; Cem Z Görgün; Gökhan S Hotamisligil
Journal:  Science       Date:  2006-08-25       Impact factor: 47.728

4.  The farnesoid X receptor promotes adipocyte differentiation and regulates adipose cell function in vivo.

Authors:  Giovanni Rizzo; Moises Disante; Andrea Mencarelli; Barbara Renga; Antimo Gioiello; Roberto Pellicciari; Stefano Fiorucci
Journal:  Mol Pharmacol       Date:  2006-06-15       Impact factor: 4.436

5.  Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation.

Authors:  Mitsuhiro Watanabe; Sander M Houten; Chikage Mataki; Marcelo A Christoffolete; Brian W Kim; Hiroyuki Sato; Nadia Messaddeq; John W Harney; Osamu Ezaki; Tatsuhiko Kodama; Kristina Schoonjans; Antonio C Bianco; Johan Auwerx
Journal:  Nature       Date:  2006-01-08       Impact factor: 49.962

6.  Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting.

Authors:  Karsten Suhre; Christa Meisinger; Angela Döring; Elisabeth Altmaier; Petra Belcredi; Christian Gieger; David Chang; Michael V Milburn; Walter E Gall; Klaus M Weinberger; Hans-Werner Mewes; Martin Hrabé de Angelis; H-Erich Wichmann; Florian Kronenberg; Jerzy Adamski; Thomas Illig
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

7.  Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance.

Authors:  Miguel López; Luis Varela; María J Vázquez; Sergio Rodríguez-Cuenca; Carmen R González; Vidya R Velagapudi; Donald A Morgan; Erik Schoenmakers; Khristofor Agassandian; Ricardo Lage; Pablo Blanco Martínez de Morentin; Sulay Tovar; Rubén Nogueiras; David Carling; Christopher Lelliott; Rosalía Gallego; Matej Oresic; Krishna Chatterjee; Asish K Saha; Kamal Rahmouni; Carlos Diéguez; Antonio Vidal-Puig
Journal:  Nat Med       Date:  2010-08-29       Impact factor: 53.440

8.  Leptin promotes biliary cholesterol elimination during weight loss in ob/ob mice by regulating the enterohepatic circulation of bile salts.

Authors:  Hideyuki Hyogo; Suheeta Roy; Beverly Paigen; David E Cohen
Journal:  J Biol Chem       Date:  2002-07-11       Impact factor: 5.157

9.  Colesevelam improves insulin resistance in a diet-induced obesity (F-DIO) rat model by increasing the release of GLP-1.

Authors:  Quan Shang; Monica Saumoy; Jens Juul Holst; Gerald Salen; Guorong Xu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-12-31       Impact factor: 4.052

10.  TGR5-mediated bile acid sensing controls glucose homeostasis.

Authors:  Charles Thomas; Antimo Gioiello; Lilia Noriega; Axelle Strehle; Julien Oury; Giovanni Rizzo; Antonio Macchiarulo; Hiroyasu Yamamoto; Chikage Mataki; Mark Pruzanski; Roberto Pellicciari; Johan Auwerx; Kristina Schoonjans
Journal:  Cell Metab       Date:  2009-09       Impact factor: 27.287

View more
  78 in total

1.  Host Genotype and Gut Microbiome Modulate Insulin Secretion and Diet-Induced Metabolic Phenotypes.

Authors:  Julia H Kreznar; Mark P Keller; Lindsay L Traeger; Mary E Rabaglia; Kathryn L Schueler; Donald S Stapleton; Wen Zhao; Eugenio I Vivas; Brian S Yandell; Aimee Teo Broman; Bruno Hagenbuch; Alan D Attie; Federico E Rey
Journal:  Cell Rep       Date:  2017-02-14       Impact factor: 9.423

2.  Association of bile acid receptor TGR5 variation and transit in health and lower functional gastrointestinal disorders.

Authors:  M Camilleri; M I Vazquez-Roque; P Carlson; D Burton; B S Wong; A R Zinsmeister
Journal:  Neurogastroenterol Motil       Date:  2011-08-24       Impact factor: 3.598

3.  Diet1 is a regulator of fibroblast growth factor 15/19-dependent bile acid synthesis.

Authors:  Karen Reue; Jessica M Lee; Laurent Vergnes
Journal:  Dig Dis       Date:  2015-05-27       Impact factor: 2.404

Review 4.  The significance of the nuclear farnesoid X receptor (FXR) in β cell function.

Authors:  Martina Düfer; Katrin Hörth; Peter Krippeit-Drews; Gisela Drews
Journal:  Islets       Date:  2012-09-01       Impact factor: 2.694

5.  Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis.

Authors:  Divya P Kumar; Amon Asgharpour; Faridoddin Mirshahi; So Hyun Park; Sichen Liu; Yumi Imai; Jerry L Nadler; John R Grider; Karnam S Murthy; Arun J Sanyal
Journal:  J Biol Chem       Date:  2016-01-12       Impact factor: 5.157

6.  Hepatic glucose sensing is required to preserve β cell glucose competence.

Authors:  Pascal Seyer; David Vallois; Carole Poitry-Yamate; Frédéric Schütz; Salima Metref; David Tarussio; Pierre Maechler; Bart Staels; Bernard Lanz; Rolf Grueter; Julie Decaris; Scott Turner; Anabela da Costa; Frédéric Preitner; Kaori Minehira; Marc Foretz; Bernard Thorens
Journal:  J Clin Invest       Date:  2013-03-15       Impact factor: 14.808

Review 7.  Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics.

Authors:  Momir Mikov; Maja Đanić; Nebojša Pavlović; Bojan Stanimirov; Svetlana Goločorbin-Kon; Karmen Stankov; Hani Al-Salami
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-06       Impact factor: 2.441

8.  Fasting serum taurine-conjugated bile acids are elevated in type 2 diabetes and do not change with intensification of insulin.

Authors:  Marlene Wewalka; Mary-Elizabeth Patti; Corinne Barbato; Sander M Houten; Allison B Goldfine
Journal:  J Clin Endocrinol Metab       Date:  2014-01-16       Impact factor: 5.958

Review 9.  Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.

Authors:  Luca Miele; Valentina Giorgio; Maria Adele Alberelli; Erica De Candia; Antonio Gasbarrini; Antonio Grieco
Journal:  Curr Cardiol Rep       Date:  2015-12       Impact factor: 2.931

Review 10.  Gut microorganisms as promising targets for the management of type 2 diabetes.

Authors:  Nathalie M Delzenne; Patrice D Cani; Amandine Everard; Audrey M Neyrinck; Laure B Bindels
Journal:  Diabetologia       Date:  2015-07-31       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.